Research and clinical data are both valuable and regulated. We monitor continuously and evidence your HIPAA, SOC 2, and ISO 27001 posture—so partners and regulators see proof, not promises.
Book a 15-minute review →Biotech and pharmaceutical companies protect clinical and research data that draws both attackers and oversight. Depending on the data, HIPAA, SOC 2, and ISO 27001 all come into play, often demanded by partners and investors.
MDRwatchdog maps continuous monitoring to the relevant frameworks, marking evidenced controls and flagging gaps, and retains a tamper-evident audit trail. One monitored environment feeds every applicable framework.
Compliance and certification are determined by the appropriate bodies; we supply monitoring and evidence, not legal advice.
For biotech and pharmaceutical companies, the most relevant frameworks are HIPAA Security Rule, SOC 2, ISO 27001. Which apply to you depends on your contracts, data, and clients.
Biotech & Pharma face protecting research data and clinical information. Continuous monitoring both detects threats and produces the ongoing evidence that compliance frameworks and client security reviews increasingly require.
Yes. One monitored environment feeds every applicable framework, so a second framework is far more efficient than the first - the underlying evidence is shared.
MDRwatchdog provides security monitoring and compliance evidence to support readiness. It is not a certification and not legal advice. Certification and formal audits are performed by the appropriate authorized bodies (a C3PAO for CMMC, a licensed CPA firm for SOC 2, an accredited body for ISO 27001).